Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y
Primary Prevention of Heart Failure in Women
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure
Heart Failure Outcomes With Volume-Guided Management